Abnoba Report issue

For profit Phase 3 Phase 4
Founded: Pforzheim Germany (1971)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2004
NCT02007005
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Abnoba Gmbh | Abnoba Korea

Active Ingredients

Drugs in Phase 4 Trials (2)

furtulon (1 trial)

mistletoe extract (1 trial)

Drugs in Phase 3 Trials (2)

abnobaviscum (3 trials)

mitomycin (mutamycin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pleural Effusion (Phase 3)

Pleural Effusion, Malignant (Phase 3)

Stomach Neoplasms (Phase 4)

Urinary Bladder Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4